TCTMD

RAISE: Reteplase May Be Another Option for Stroke Thrombolysis

Reteplase appears to be another safe and effective thrombolytic option for the treatment of acute ischemic stroke, according to results from the randomized RAISE trial. When given within the first 4.5 ...
TCTMD

AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline

A new guideline on the early management of acute ischemic stroke released this week by the American Heart Association/American Stroke Association (AHA/ASA) revamps guidance on prehospital care, use of ...
Medscape

Tenecteplase Gains Ground as a Go-To Stroke Thrombolytic

BARCELONA, Spain — A new individual patient-level meta-analysis confirms that the newer bolus thrombolytic, tenecteplase, is noninferior to alteplase for acute ischemic stroke — and may even offer ...
Business Wire

Basking Biosciences Doses First Patients in Phase 2 Clinical Trial of Reversible Thrombolytic BB-031 for Acute Ischemic Stroke

COLUMBUS, Ohio--(BUSINESS WIRE)--Basking Biosciences (Basking), a clinical-stage biopharmaceutical company developing a novel acute thrombolytic therapy, today announced that the first patients have ...